Combination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cells.

Lee, Pei-Chih

Combination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cells. [electronic resource] - Neoplasia (New York, N.Y.) May 2010 - 376-87 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1476-5586

10.1593/neo.10110 doi


Animals
Antineoplastic Agents, Alkylating--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Apoptosis
Arsenic Trioxide
Arsenicals--administration & dosage
Blotting, Western
Carbamates--administration & dosage
Cell Line, Tumor
Cell Proliferation--drug effects
Cell Separation
Drug Resistance, Neoplasm--drug effects
Drug Synergism
Flow Cytometry
Fluorescent Antibody Technique
Heterocyclic Compounds, 3-Ring--administration & dosage
Humans
Immunohistochemistry
In Situ Nick-End Labeling
Male
Mice
Mice, Nude
Neoplasms, Experimental--drug therapy
Oxides--administration & dosage
Signal Transduction--drug effects
Xenograft Model Antitumor Assays